2024 |
Annexon Inc
|
Chairman of the Board |
- |
- |
2024 |
Jasper Therapeutics Inc
|
Chairman of the Board |
- |
- |
2023 |
Annexon Inc
|
Chairman of the Board |
132.4 K |
-9.8 % |
2023 |
Jasper Therapeutics Inc
|
Chairman of the Board |
76.5 K |
- |
2023 |
Jasper Therapeutics Inc - Warrants (24/09/2026)
|
Chairman of the Board |
- |
- |
2023 |
Cymabay Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Cymabay Therapeutics Inc
|
Independent Director |
207.9 K |
-38.6 % |
2022 |
Annexon Inc
|
Chairman of the Board |
146.9 K |
-35.7 % |
2021 |
Cymabay Therapeutics Inc
|
Independent Director |
338.5 K |
- |
2021 |
Annexon Inc
|
Chairman of the Board |
228.3 K |
117.2 % |
2020 |
Annexon Inc
|
Chairman of the Board |
105.1 K |
192.2 % |
2020 |
Cymabay Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Annexon Inc
|
Independent Director |
36.0 K |
- |
2012 |
Sangamo Therapeutics Inc
|
- |
17.5 K |
-77.9 % |
2012 |
Sangamo Therapeutics Inc
|
Independent Director |
- |
- |
2011 |
Sangamo Therapeutics Inc
|
Independent Director |
79.3 K |
20.1 % |
2010 |
Sangamo Therapeutics Inc
|
Director |
66.0 K |
28.1 % |
2009 |
Sangamo Therapeutics Inc
|
Director |
51.5 K |
-14.9 % |
2008 |
Sangamo Therapeutics Inc
|
Director |
60.5 K |
- |
2007 |
Sangamo Therapeutics Inc
|
Director |
- |
- |